Physician profile
Elizabeth Wang
NPI 1558919183
$3,464.69
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,340 · 2022: $2,080 · 2023: $45.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $45.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $45.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $560.38 | 2021-2023 | |
| Lilly USA, LLC | $527.20 | 2021-2022 | |
| Novo Nordisk INC | $491.59 | 2021-2022 | |
| Amarin Pharma, INC. | $297.58 | 2021-2022 | |
| Amgen INC. | $261.85 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $173.93 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $126.35 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.48 | 2021-2022 | |
| Pfizer INC. | $107.95 | 2021-2022 | |
| Aprecia Pharmaceuticals, LLC | $106.41 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $102.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $92.21 | 2021-2022 | |
| Astellas Pharma US INC | $85.99 | 2021-2023 | Myrbetriq |
| Novartis Pharmaceuticals Corporation | $70.10 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.56 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $49.16 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $48.98 | 2022 | |
| Biogen, INC. | $37.48 | 2021 | |
| Upsher-Smith Laboratories LLC | $30.58 | 2021 | |
| Esperion Therapeutics, INC. | $29.91 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.08 | 2021 | |
| Sanofi-Aventis U.S. LLC | $21.41 | 2022 | |
| Merck Sharp & Dohme LLC | $17.54 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.56 | 2022 | |
| Mylan Specialty L.P. | $12.92 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.